Tetsuya Shindo

发表

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer

Naoya Masumori, Hiromu Suzuki, R. Maruyama, 2018, Oncotarget.

Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2018, International Journal of Clinical Oncology.

Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2018, Japanese journal of clinical oncology.

Bacillus Calmette-Guérin may have clinical benefit for glandular or squamous differentiation in non-muscle invasive bladder cancer patients: retrospective multicenter study

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2018, Japanese journal of clinical oncology.

Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment

Tetsuya Shindo, N. Masumori, H. Kitamura, 2014, International Journal of Clinical Oncology.

The primary local stage at diagnosis predicts regional symptoms caused by local progression in patients with castration-resistant prostate cancer.

Tetsuya Shindo, N. Masumori, H. Kitamura, 2015, Urology.

Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma

H. Nishiyama, S. Anai, A. Yokomizo, 2020, Cancer science.

A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.

Tetsuya Shindo, N. Masumori, H. Kitamura, 2012, Japanese journal of clinical oncology.

Influence of body mass index and total testosterone level on biochemical recurrence following radical prostatectomy.

Tetsuya Shindo, T. Tsukamoto, Sachiyo Nishida, 2008, Japanese journal of clinical oncology.

Can levocarnitine supplementation improve fatigue caused by sunitinib as a treatment for renal cell carcinoma? A single-center prospective pilot study

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2018, Supportive Care in Cancer.

[Dosing Schedules and Outcomes in Patients Treated with First-Line Sunitinib for Advanced Renal Cell Carcinoma].

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2016, Hinyokika kiyo. Acta urologica Japonica.

Molecular-targeted Therapy and Surgery May Prolong Survival of Renal Cell Carcinoma Patients with Bone Metastasis: A Multi-institutional Retrospective Study in Japan.

Tetsuya Shindo, N. Masumori, H. Kitamura, 2016, Anticancer research.

Long‐term outcome of small, organ‐confined renal cell carcinoma (RCC) is not always favourable

Tetsuya Shindo, N. Masumori, H. Kitamura, 2013, BJU international.

[EFFICACY OF NEOADJUVANT GEMCITABINE AND CISPLATIN IN THE MANAGEMENT OF MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER].

Tetsuya Shindo, N. Itoh, K. Hashimoto, 2015, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2021, Journal of Bone and Mineral Metabolism.

[The effect of presurgical gemcitabine cisplatin chemotherapy for urothelial carcinoma].

Tetsuya Shindo, N. Masumori, H. Kitamura, 2012, Hinyokika kiyo. Acta urologica Japonica.

Successful Treatment by Surgery and Lenvatinib of a Patient with Adrenal Metastasis of Papillary Thyroid Cancer

Tetsuya Shindo, N. Masumori, S. Sugita, 2020, Case reports in oncological medicine.

Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC)

Tetsuya Shindo, N. Masumori, H. Kitamura, 2014, World Journal of Urology.

Serum testosterone level is a useful biomarker for determining the optimal treatment for castration-resistant prostate cancer.

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2019, Urologic oncology.

Second transurethral resection against Ta high grade tumor : Residual location and predictive factor. A single center, retrospective study

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2018 .

DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling

Hiromu Suzuki, R. Maruyama, M. Kai, 2018, Haematologica.

External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort.

H. Miyake, S. Anai, A. Yokomizo, 2021, Japanese journal of clinical oncology.

Editorial Comment to Case of hydrocele testis caused by vaginalitis, a rare manifestation of immunoglobulin G4‐related disease

Tetsuya Shindo, 2017, International journal of urology : official journal of the Japanese Urological Association.

Intrinsic and extrinsic factors causing hyperplasia of the prostate

Tetsuya Shindo, N. Masumori, F. Fukuta, 2024, International journal of urology : official journal of the Japanese Urological Association.

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

H. Shiina, S. Anai, A. Yokomizo, 2023, Urologic oncology.

Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2020, Cancer medicine.

A case of metastatic Xp11.2 translocation renal cell carcinoma showing a prolonged response to nivolumab as 6th-line treatment

Tetsuya Shindo, N. Masumori, T. Hasegawa, 2022, International Cancer Conference Journal.

Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy

Tetsuya Shindo, N. Masumori, R. Kato, 2023, Supportive Care in Cancer.

Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy

Tetsuya Shindo, N. Masumori, R. Kato, 2024, AntiCancer Research.

Maternal diet during gestation affect prostatic tissue component in SHR/Izm offspring

Hiromu Suzuki, Tetsuya Shindo, N. Masumori, 2023, The Prostate.